China · Delayed Price · Currency is CNY Jiangsu Nhwa Pharmaceutical Co., LTD Company Description
Jiangsu Nhwa Pharmaceutical Co., LTD engages in research, development, production, and sale of central nervous system products in China.
The company offers APIs, solid preparation, water injection, and freeze-dried powder formulations for depression, anxiety disorders, insomnia, severe mental disorders, and neurodegenerative diseases.
Its products include sufentanil citrate injection, oxaliplatin fumarate injection, alfentanil hydrochloride injection, oxycodone hydrochloride injection, olanzapine tablets, midazolam hydrochloride oral solution, clonazepam injection, lacosamide injection, micuronium injection, pregabalin capsules, vortioxetine hydrobromide tablets, tapentadone hydrochloride tablets, and oxycodone hydrochloride extended-release tablets.
The company was founded in 1978 and is headquartered in Xuzhou, China.
| Country | China |
| Founded | 1978 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 6,003 |
| CEO | Jiaquan Sun |
Contact Details
Address: Enhua Technology Building Xuzhou, Jiangsu Province 221009 China | |
| Phone | 86 40 0900 2262 |
| Website | nhwa-group.com |
Stock Details
| Ticker Symbol | 002262 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100000CG8 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jiaquan Sun | GM and Non-Independent Director |
| Gangsheng Li | Chief Financial Officer |
| Qing Fu | Deputy GM and Non-Independent Director |
| Zengliang Chen | Deputy GM and Non-Independent Director |
| Ziliang Yang | Deputy GM and Non-Independent Director |
| Bao Zhou Duan CPA | Deputy GM and Secretary |
| Ji Rui Hu | Accounting Supervisor |